AMT-080 regulatory update

FDA granted Orphan Drug designation for Amsterdam Molecular's AMT-080 to treat Duchenne muscular dystrophy (DMD). The U1 small nuclear RNA (snRNA) targeting exon 51 of the dystrophin gene is in precl...